Rareness is one factor in choosing a specialist

BY DR. DAVID LIPSCHITZ Modified: July 16, 2012 at 11:26 am •  Published: July 16, 2012
Advertisement
;

Walking down the corridors of the medical school where I spent the majority of my working years — the University of Arkansas for Medical Sciences — is like being at the United Nations. Patients come from all over the world to see Dr. Bart Barlogie, a pioneer researcher and leading expert in treating multiple myeloma, a tumor affecting bone marrow.

Until recently, myeloma was universally fatal. Thanks to breakthroughs in the care of this disease, Barlogie and his team regularly see patients who have survived 10 years or more. And there is talk of cure.

Many of the advances have come from the work of Barlogie, who not only treats myeloma but also has spent his career studying the fundamental mechanisms that cause bone marrow plasma cells to transform into a malignancy.

If someone has multiple myeloma, is there merit to coming to this medical school to be treated at a cost of traveling thousands of miles from home, spending time surrounded by strangers, living in motels and away from friends and family? In my view, if it is feasible, the sacrifices are worth it.

Myeloma is quite rare, and because so many patients come to be treated at a single center, greater experience and understanding of the disease are acquired.

Barlogie's experience allows him to provide unique approaches to care, particularly for those patients where relapses have occurred and treatment has become more difficult. In these cases, care requires a physician scientist who truly makes the art of medicine a reality.

But should a patient travel to a special center to receive treatment for the very common illnesses that afflict us? The American Cancer Society reports that in 2008, 12 million people were diagnosed with cancer.

Of these, 2.6 million had breast cancer, 1.1 million colorectal cancer, 2.3 million prostate cancer and 400,000 had lung cancer. Compared with those numbers, 64,000 were diagnosed with multiple myeloma.

Because of the large number of patients diagnosed with common cancers, every metropolitan center has specialists who can provide world-class, state-of-the-art care for these diseases, making traveling to a faraway major center unnecessary.

For other common illnesses such as coronary artery disease, osteoarthritis or back pain, every community has experts equal to those found in even the most prestigious institutions.

But how does a patient choose the right physician? Many insurance companies tout not requiring a referral to a specialist as a major benefit of their plan. Many of these visits are unnecessary, and frequently, the best specialist for the problem was not chosen.

Continue reading this story on the...